Stocks & ETFs Screener: 167 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Diabetes Treatments, Cancer |
636B | 77.9% | 66.1% | 33.9% | 46.4 | -34.0% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, MedicalDevices |
431B | 75.3% | 59.9% | 30.7% | 19.2 | -6.11% |
| ROG Roche Holding |
Pharmaceuticals
Pharmaceuticals, Diagnostics |
262B | 78.7% | 57.9% | -11.9% | 22.4 | -18.8% |
| RO Roche Holding |
Pharmaceuticals
Pharmaceuticals, Diagnostics |
261B | 83.1% | 57.3% | -8.87% | 23.3 | -20.3% |
| ZEG AstraZeneca |
Pharmaceuticals
Cancer Drugs, Heart Drugs, Lung |
249B | 81.6% | 44.7% | 21.6% | 29.9 | -24.2% |
| AZN AstraZeneca |
Pharmaceuticals
Cancer, Cardiovascular |
247B | 80.2% | 41.9% | 34.1% | 30.0 | -20.6% |
| NVO Novo Nordisk |
Pharmaceuticals
Diabetes, Obesity, Insulin |
247B | 89.9% | 65.1% | 2.46% | 14.3 | -63.6% |
| NOVN Novartis |
Pharmaceuticals
Pharmaceuticals, Medicines |
235B | 93.1% | 62.3% | 54.3% | 17.6 | -12.0% |
| NVS Novartis |
Pharmaceuticals
Pharmaceuticals, HeartFailure |
235B | 77.9% | 62.8% | 68.0% | 17.7 | -7.20% |
| MRK Merck |
Pharmaceuticals
Pharmaceuticals, Vaccines |
215B | 84.8% | 74.1% | -13.2% | 13.3 | -37.7% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
146B | 64.7% | 74.6% | -38.6% | 13.6 | -22.2% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
123B | 57.0% | 58.1% | 11.4% | 16.8 | -21.0% |
| SAN Sanofi |
Pharmaceuticals
Medicines, Vaccines, Oncology |
121B | 69.1% | 66.2% | 1.84% | 16.6 | -25.0% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
95.4B | 73.1% | 63.7% | -22.1% | 18.8 | -15.0% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
79.9B | 77.7% | 33.2% | 23.3% | 17.8 | -20.2% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
78.1B | 66.2% | 28.9% | 18.0% | 17.3 | -23.2% |
| ZTS Zoetis |
Pharmaceuticals
Animal Medicine, Vaccines |
68.3B | 87.0% | 62.8% | -30.2% | 26.5 | -27.2% |
| MRK Merck KGaA |
Pharmaceuticals
LifeScienceTools, HealthcareDrugs |
56.2B | 57.5% | 40.2% | -41.6% | 16.8 | -46.4% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology,Rare,Disease,Plasm.. |
47.8B | 61.6% | 35.2% | 20.3% | 51.3 | -11.0% |
| UCB UCB |
Pharmaceuticals
Cimzia, Vimpat, Keppra, Briviact |
44.3B | 75.5% | 45.4% | 42.1% | 29.2 | 5.82% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
30.9B | 44.5% | 0.40% | -23.1% | - | -13.6% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Cancer, Rare Disease |
20.9B | 51.3% | 68.0% | 19.2% | 15.7 | 8.0% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, Corticosteroid |
20.8B | 59.0% | 18.5% | 15.7% | - | -17.4% |
| VTRS Viatris |
Pharmaceuticals
Generic Drugs, Biosimilars |
12.5B | 28.5% | 58.9% | -41.5% | - | -22.1% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generic Medicines, Active |
11.9B | 76.7% | 49.8% | 3.57% | 18.1 | -27.1% |
| IPN Ipsen |
Pharmaceuticals
Oncology Drugs, Neuroscience |
11.4B | 84.0% | 49.8% | 21.6% | 22.0 | -5.89% |
| SOBI Swedish Orphan |
Pharmaceuticals
Haematology, Immunology, Specialty |
10.5B | 69.9% | - | 8.57% | 23.1 | -22.0% |
| VRNA Verona Pharma |
Pharmaceuticals
Inhaled |
8.96B | 41.8% | - | 96.2% | - | 234% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
8.70B | 58.1% | - | -19.6% | 19.9 | 2.94% |
| TUB Tubize-Fin |
Pharmaceuticals
Stake, Investment, UCB, Biopharma |
8.14B | 34.0% | 56.2% | 45.1% | 75.5 | 18.3% |
| CORT Corcept |
Pharmaceuticals
Hormonemodulator, Korlym |
7.41B | 82.4% | - | 88.0% | 62.8 | 71.7% |
| JAZZ Jazz |
Pharmaceuticals
Oxybate,Sleep,Seizure,Cancer,HEMATO.. |
7.14B | 59.8% | - | -14.7% | - | -7.90% |
| KRK Krka d. d |
Pharmaceuticals
Cardiovascular, Antibiotics |
7.05B | 68.7% | 85.0% | 94.1% | 14.8 | 27.3% |
| SECT-B Sectra (publ) |
Pharmaceuticals
Medical IT Systems, Cybersecurity |
7.04B | 90.4% | 42.7% | 73.0% | 119 | 20.1% |
| HLUN-A H Lundbeck |
Pharmaceuticals
Psychiatric, Neurological |
5.90B | 68.4% | 59.2% | -13.6% | 9.36 | -28.2% |
| HLUN-B H Lundbeck |
Pharmaceuticals
Pharmaceuticals, Neurological |
5.84B | 69.8% | 57.8% | -1.79% | 11.1 | -26.4% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Auvelity, Sunosi, Symbravo, AXS-05 |
5.45B | 28.7% | - | 56.2% | - | 17.0% |
| SFZN Siegfried Holding |
Pharmaceuticals
API, Finished Dosage, Steriles |
4.62B | 78.3% | 46.7% | -1.92% | 23.0 | -33.8% |
| CAMX Camurus |
Pharmaceuticals
Opioid Treatment, Pain Relief |
4.04B | 87.2% | - | 55.6% | 54.0 | -11.7% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.36B | 83.3% | 52.5% | 17.0% | 19.5 | -13.9% |
| PBH Prestige Brand |
Pharmaceuticals
Pain Powders, Diaper Rash Cream |
3.19B | 64.4% | 0.21% | 40.7% | 15.2 | -22.5% |
| PRGO Perrigo |
Pharmaceuticals
Cough Relief, Infant Formula |
3.17B | 53.4% | 70.9% | -43.6% | - | -28.1% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
2.97B | 65.8% | - | 29.1% | 945 | -5.75% |
| HCM HUTCHMED DRC |
Pharmaceuticals
Fruquintinib, Savolitinib |
2.79B | 39.4% | - | -46.3% | 6.12 | -27.2% |
| BHC Bausch Health |
Pharmaceuticals
Prescription,Surgical,Ophthalmology.. |
2.66B | 65.0% | 4.65% | -46.6% | 27.6 | 2.98% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
2.45B | 50.7% | 50.2% | -84.5% | 3.51 | -63.9% |
| SUPN Supernus |
Pharmaceuticals
ADHD,Parkinsons,Epilepsy,Migraine,M.. |
2.39B | 70.6% | - | 41.6% | 37.1 | 11.3% |
| LQDA Liquidia |
Pharmaceuticals
Inhaled,Liquid,Artery,Cancer,Pulmon.. |
2.35B | 23.0% | - | 86.7% | - | 145% |
| TARS Tarsus |
Pharmaceuticals
Demodex, Blepharitis, Mites, Eye |
2.31B | 29.5% | - | 49.3% | - | 85.9% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Hydrogel,Eye,Injection,Sustained-Re.. |
2.20B | 26.3% | - | 13.9% | - | 18.3% |
| HRMY Harmony |
Pharmaceuticals
Medication, Wakix, Narcolepsy |
2.12B | 87.7% | - | -6.88% | 11.9 | -9.01% |
| DMP Dermapharm Holding |
Pharmaceuticals
Generics, Biosimilars |
2.11B | 76.5% | 46.2% | -19.0% | 17.5 | -16.0% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Prescription, Specialty, Generic |
1.98B | 58.9% | - | 79.4% | - | 25.4% |
| FAGR Fagron |
Pharmaceuticals
Pharmaceutical Compounding |
1.77B | 87.4% | 58.0% | 37.3% | 17.8 | -4.72% |
| BGM Qilian |
Pharmaceuticals
Pharmaceutical Ingredients |
1.58B | 30.2% | 1.0% | -14.0% | - | 10.2% |
| WVE Wave Life Sciences |
Pharmaceuticals
Genetic, Therapy, DNA, RNA |
1.51B | 31.2% | - | -2.44% | - | 51.0% |
| HROW Harrow Health |
Pharmaceuticals
Pharmaceutical,Imprinted,Drogs,Oint.. |
1.45B | 32.3% | - | 32.3% | - | -16.3% |
| AMPH Amphastar P |
Pharmaceuticals
Enoxaparin, Insulin, Glucagon |
1.41B | 77.4% | - | -11.6% | 11.4 | -47.1% |
| AVDL Avadel |
Pharmaceuticals
Hypnotic, Narcolepsy, Lymphatic |
1.33B | 59.4% | - | 21.6% | - | -16.4% |
| PAHC Phibro Animal |
Pharmaceuticals
Animal Health, Medicated Feed |
1.32B | 49.2% | 40.8% | 45.8% | 41.9 | 60.4% |
| INVA Innoviva |
Pharmaceuticals
Antibiotics, Respiratory |
1.32B | 65.9% | 2.39% | 31.7% | 36.7 | -11.2% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverage, Wellness |
1.26B | 47.1% | - | -74.5% | - | -26.5% |
| EVT Evotec SE |
Pharmaceuticals
Drug Discovery, Small Molecules |
1.26B | 44.8% | - | -48.5% | - | -20.3% |
| XERS Xeris |
Pharmaceuticals
Injectable, Glucagon, Diabetes |
1.19B | 40.1% | - | 51.2% | - | 141% |
| COLL Collegium |
Pharmaceuticals
Oxycodone, Hydrocodone, Opioid |
1.19B | 70.7% | - | 27.3% | 35.5 | -12.1% |
| ELVN Enliven |
Pharmaceuticals
Kinase,Inhibitors,Oncology,Pipeline |
1.17B | 27.7% | - | -54.7% | - | -22.8% |
| PPGN PolyPeptide |
Pharmaceuticals
Peptides, Active, Ingredients |
1.16B | 44.3% | 1.0% | -65.9% | - | -30.2% |
| PCRX Pacira BioSciences |
Pharmaceuticals
Bupivacaine,Anesthetic,Injectable |
1.11B | 45.8% | - | -8.97% | - | 53.1% |
| COPN COSMO |
Pharmaceuticals
Pharmaceutical, Gastrointestinal |
1.11B | 89.8% | 47.3% | -42.0% | 16.6 | -30.6% |
| VETO Vetoquinol |
Pharmaceuticals
Medications, Vaccines |
1.03B | 86.3% | 59.2% | -25.9% | 15.1 | -31.1% |
| CRMD CorMedix |
Pharmaceuticals
Antibiotic, Dialysis, Catheter |
975M | 69.5% | - | 54.7% | 16.7 | 103% |
| CRON Cronos |
Pharmaceuticals
Cannabis, Edibles, Oils, Vapes |
954M | 58.3% | - | -35.8% | 49.6 | 2.76% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Investigational, Therapy, Chronic |
891M | 28.9% | - | 60.1% | - | 108% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Digital Asset Trading |
840M | 36.6% | - | 34.5% | - | 206% |
| EYPT Eyepoint |
Pharmaceuticals
DURAVYU, EYP-2301, Durasert E |
781M | 21.7% | - | 28.7% | - | 11.8% |
| PHAT Phathom |
Pharmaceuticals
Gastrointestinal, Treatments |
736M | 45.6% | - | -59.7% | - | -35.2% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
697M | 38.4% | - | -6.39% | - | 283% |
| BIOA BioAge Labs |
Pharmaceuticals
Oral Small Molecules, Obesity |
674M | 32.1% | - | -81.5% | - | -77.1% |
| TBPH Theravance |
Pharmaceuticals
YUPELRI, Ampreloxetine, TRELEGY |
662M | 44.6% | - | 16.7% | 54.8 | 45.5% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Wine, Beers, Spirits |
651M | 44.5% | - | -29.9% | - | 19.1% |
| TERN Terns |
Pharmaceuticals
Oncology, Obesity, Cancer |
617M | 22.4% | - | -51.9% | - | -22.0% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Pharmaceuticals |
609M | 84.3% | 88.0% | 16.8% | 7.46 | -16.4% |
| ARVN Arvinas |
Pharmaceuticals
Protein Degraders, PROTAC, Cancer |
537M | 20.8% | - | -77.8% | - | -74.4% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Small Molecule Inhibitors, Kidney |
525M | 49.3% | - | 0.41% | - | -17.3% |
| RAPP Rapport |
Pharmaceuticals
SmallMolecule, CNS, RAP-219 |
520M | 22.1% | - | -63.6% | 11.9 | -29.3% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Oncology, Antiviral, Immunology |
508M | 33.6% | - | -36.8% | - | 31.9% |
| AQST Aquestive |
Pharmaceuticals
Film,Klaxx,Film,Sublingual,Epinephr.. |
481M | 31.8% | - | -41.7% | - | -28.5% |
| BOI Boiron |
Pharmaceuticals
Homeopathic, Pellets, Tablets |
445M | 77.3% | 64.8% | -41.3% | 32.9 | -42.5% |
| SEPN Septerna, Common |
Pharmaceuticals
Oral Small Molecules, GPCR |
444M | 34.0% | - | -64.2% | - | -39.7% |
| EOLS Evolus |
Pharmaceuticals
Jeuveau, Evolysse |
435M | 34.1% | - | -8.16% | - | -59.7% |
| ETON Eton |
Pharmaceuticals
Rare Disease Treatments |
434M | 42.9% | - | 56.5% | - | 219% |
| FULC Fulcrum |
Pharmaceuticals
Small Molecules, Fetal Hemoglobin |
353M | 31.8% | - | -8.99% | - | -36.3% |
| EAPI Euroapi SAS |
Pharmaceuticals
ActivePharmaceuticalIngredients |
349M | 48.6% | - | -73.2% | - | -36.4% |
| CLN Celon Pharma |
Pharmaceuticals
Medications, Therapies |
334M | 36.9% | 9.10% | -57.9% | - | -37.2% |
| CGC Canopy Growth |
Pharmaceuticals
Cannabis, Hemp, Extracts, Edibles |
334M | 13.8% | - | -90.0% | - | -69.8% |
| OMER Omeros |
Pharmaceuticals
Drug, Omid, Pegcetacoplan |
298M | 35.5% | - | -41.6% | - | -11.0% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Cannabis-Derivative |
286M | 49.4% | - | -58.0% | - | -19.2% |
| AARD Aardvark |
Pharmaceuticals
SmallMolecule Therapeutics, Oral |
284M | 14.1% | - | -37.2% | - | -44.6% |
| AVIR Atea |
Pharmaceuticals
Antiviral Therapeutics, Hepatitis |
277M | 28.6% | - | -50.7% | - | -22.4% |
| KG KING |
Pharmaceuticals
Cardiovascular,Neuroscience,Medicin.. |
273M | 47.6% | 14.2% | -33.1% | 916 | -36.4% |
| NMRA Neumora |
Pharmaceuticals
Depression, Schizophrenia |
266M | 18.7% | - | -87.5% | - | -87.1% |
| TVRD Tvardi |
Pharmaceuticals
STAT3, Inhibitor, Cancer |
242M | 42.3% | - | -15.6% | - | 101% |
| SCPH Scpharmaceuticals |
Pharmaceuticals
Furosemide, Infusor, Diuretic |
238M | 41.5% | - | -19.1% | - | -4.83% |
| ZYBT Zhengye |
Pharmaceuticals
Veterinary Vaccines, Livestock |
235M | 41.4% | - | 79.8% | 83.2 | 64.6% |
| CTNM Contineum |
Pharmaceuticals
CNS,Pain,Inflammation |
227M | 19.8% | - | -84.5% | - | -53.8% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Vapes, Beverages |
210M | 43.5% | - | -62.1% | 157 | -20.1% |
| JUNS Jupiter |
Pharmaceuticals
Resveratrol, Pharmaceuticals |
200M | 26.3% | - | -52.9% | - | -75.5% |
| ACRS Aclaris |
Pharmaceuticals
Hair Loss, Skin Lesion, Immune |
194M | 23.7% | - | -12.0% | - | 30.3% |
| MDWD Mediwound |
Pharmaceuticals
BurnTreatment, WoundCare |
191M | 33.6% | - | -8.68% | - | -25.4% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Amphiphile,Lymph,Node,Cancer,Vaccin.. |
188M | 41.6% | - | -15.5% | - | 121% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
Drug, Immune, Skin, Bowel |
188M | 35.1% | - | -44.8% | - | -5.37% |
| MIST Milestone |
Pharmaceuticals
Cardiovascular, Drug Development |
144M | 21.8% | - | -39.3% | - | 6.07% |
| SCLX Scilex Holding |
Pharmaceuticals
Topical, Non-Opioid, Pain Relief |
122M | 54.1% | - | -84.4% | - | -60.1% |
| CRAD-B C-Rad (publ) |
Pharmaceuticals
Radiotherapy, Imaging, Workflow |
118M | 67.4% | - | -22.0% | 44.1 | -34.1% |
| SAVA Cassava Sciences |
Pharmaceuticals
Alzheimers Drug, Pipeline |
109M | 28.4% | 0.17% | -51.9% | - | -92.4% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressants, Bipolar |
107M | 25.9% | - | -89.3% | - | -72.7% |
| APPH Apontis Pharma |
Pharmaceuticals
Cardiovascular, Respiratory |
105M | 26.7% | - | 5.40% | 121 | 31.0% |
| BACTI-B Bactiguard Holding |
Pharmaceuticals
Urology, Infection, Prevention |
97.5M | 49.7% | - | -85.7% | - | -64.2% |
| AB AB Science S.A |
Pharmaceuticals
Tyrosine Kinase Inhibitors |
96.2M | 52.7% | - | -29.1% | - | 1.50% |
| NTHI NeOnc Technologies |
Pharmaceuticals
Brain, Tumor, Cancer, Drugs |
90.8M | 35.5% | - | -76.7% | - | -49.7% |
| 93M1 MPH Health Care |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
90.3M | 73.3% | 39.8% | -26.8% | 2.42 | -13.9% |
| ORMP Oramed |
Pharmaceuticals
Oral Insulin, Oral Vaccines |
87.8M | 44.4% | - | -51.3% | - | -22.1% |
| CNTX Context |
Pharmaceuticals
Bispecific Antibodies, Claudin 6 |
78.3M | 28.5% | - | -74.3% | - | -70.6% |
| ORX Orexo |
Pharmaceuticals
Zubsolv, Abstral, Edluar |
76.1M | 43.5% | - | -10.3% | - | 10.6% |
| ASRT Assertio |
Pharmaceuticals
INDOCIN, Sympazan, CAMBIA, SPRIX |
75.6M | 33.9% | - | -71.6% | - | -41.1% |
| SLGL Sol Gel |
Pharmaceuticals
Topical, Dermatological, Drugs |
65.5M | 30.2% | - | -21.3% | - | 183% |
| ENZY Enzymatica publ |
Pharmaceuticals
ColdZyme, Cold Spray, Enzyme |
59.9M | 36.5% | - | -24.8% | - | 3.71% |
| DRRX Durect |
Pharmaceuticals
Larsucosterol, POSIMIR, PERSERIS |
59.0M | 33.8% | - | -53.4% | - | 18.6% |
| KALA Kala |
Pharmaceuticals
Eye Disease Therapies, Corneal |
58.6M | 18.8% | - | -42.4% | - | 52.5% |
| VRCA Verrica |
Pharmaceuticals
Wart, Molluscum, Skin Cancer |
51.6M | 42.4% | - | -81.8% | - | -79.8% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Metal Ion |
48.1M | 31.6% | - | -93.3% | - | -75.3% |
| CPIX Cumberland |
Pharmaceuticals
Acetadote, Caldolor, Kristalose |
46.8M | 47.5% | - | 24.9% | - | 117% |
| ITRM Iterum Therapeutics |
Pharmaceuticals
Oral Antibiotic, Anti-Infective |
38.5M | 30.6% | - | -73.6% | - | -46.5% |
| IRD Opus Genetics |
Pharmaceuticals
Eye Drops, Retinal Therapy, Vision |
35.7M | 41.9% | - | -63.1% | - | -17.1% |
| QLINEA Q linea |
Pharmaceuticals
Diagnostic, Instrument, Kit |
35.0M | 33.3% | - | -89.7% | - | -92.2% |
| GRCE Grace Therapeutics |
Pharmaceuticals
Intravenous Infusion, Oral Spray |
35.0M | 30.9% | - | -36.2% | - | 0.43% |
| SCYX Scynexis |
Pharmaceuticals
Antifungal Medicines, Brexafemme |
34.1M | 30.0% | - | -85.0% | - | -50.7% |
| CLSD Clearside |
Pharmaceuticals
XIPERE,CLS-AX,Injectable,Suspension.. |
31.6M | 46.2% | - | -81.1% | - | -67.1% |
| AKTX Akari Therapeutics |
Pharmaceuticals
Inflammatory, Autoimmune |
30.2M | 29.2% | - | -82.2% | - | -82.0% |
| MIRA MIRA |
Pharmaceuticals
Ketamine Analog, Pharmaceutical |
27.5M | 34.8% | - | -46.6% | - | -30.8% |
| KDEV Karolinska |
Pharmaceuticals
Pharmaceuticals, Biotechnology |
27.5M | 40.5% | - | -64.2% | - | -35.3% |
| SNES SenesTech |
Pharmaceuticals
ContraPest, Evolve, Mouse |
24.0M | 48.7% | - | -38.1% | - | 31.1% |
| ALTHX Theranexus |
Pharmaceuticals
Drug Candidates, CNS Disorders |
23.8M | 45.3% | - | -20.7% | - | 212% |
| CTXR Citius |
Pharmaceuticals
Cancer, Immunotherapy, Antibiotic |
20.9M | 29.3% | - | -85.3% | - | -91.8% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release Formulation |
20.6M | 47.7% | - | -73.8% | - | -74.6% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Instaprin, Sublingual Delivery |
20.2M | 38.4% | - | -72.1% | - | -95.8% |
| SBX SynBiotic SE |
Pharmaceuticals
Cannabinoids, Terpenes, Wellness |
20.0M | 38.7% | - | -84.1% | - | -57.2% |
| AYTU Aytu BioScience |
Pharmaceuticals
Adhd, Antihistamine |
19.8M | 36.4% | - | -55.6% | - | -18.6% |
| ADGM Adagio Medical |
Pharmaceuticals
Atrial, Cryoablation, Catheters |
19.2M | 31.7% | - | -76.3% | - | -66.3% |
| PULM Pulmatrix |
Pharmaceuticals
iSPERSE, PUR1800, PUR1900, PUR3100 |
17.2M | 26.1% | - | -16.8% | - | 104% |
| HOTH Hoth Therapeutics |
Pharmaceuticals
Skin, Brain, Allergy |
17.1M | 21.8% | - | -28.8% | - | 45.4% |
| LPCN Lipocine |
Pharmaceuticals
Testosterone, Neurology, Obesity |
16.4M | 24.9% | - | -78.4% | - | -31.6% |
| COCP Cocrystal Pharma |
Pharmaceuticals
Antiviral, Influenza, Coronavirus |
15.5M | 50.0% | - | -71.1% | - | -28.3% |
| GELS Gelteq Ordinary |
Pharmaceuticals
Edible Gels, Nutraceuticals, Pet |
14.2M | 20.0% | - | -72.4% | - | -60.7% |
| PRPH ProPhase Labs |
Pharmaceuticals
Dietary Supplements, COVID-19 |
13.9M | 18.1% | 1.0% | -77.1% | - | -87.4% |
| TXMD TherapeuticsMD |
Pharmaceuticals
Prescription Pharmaceuticals |
12.7M | 58.5% | 0.07% | -78.7% | - | -50.9% |
| ARTL Artelo Biosciences |
Pharmaceuticals
Therapeutic, Candidates |
12.5M | 38.8% | - | -42.3% | - | 2.42% |
| TLPH Talphera |
Pharmaceuticals
Niyad, LTX-608, Fedsyra |
9.98M | 29.9% | - | -90.1% | - | -50.1% |
| TRAW Traws Pharma |
Pharmaceuticals
Antiviral, Anticancer, Influenza |
9.96M | 55.7% | - | -89.5% | 0.34 | -86.2% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal, Spray, Gastroparesis |
9.88M | 42.3% | - | -57.8% | - | 2.26% |
| SNOA Sonoma |
Pharmaceuticals
Skin Care, Wound Care, Eye Care |
8.79M | 38.7% | - | -35.1% | - | 19.1% |
| ADIL Adial |
Pharmaceuticals
Alcohol Treatment, Pain |
8.12M | 46.7% | - | -91.7% | - | -65.7% |
| TTNP Titan |
Pharmaceuticals
Implantable, Drug, Delivery |
6.48M | 25.7% | 0.10% | -62.4% | - | -44.8% |
| NBY NovaBay |
Pharmaceuticals
Eyecare, Wound Care, Skin Care |
5.99M | 43.6% | - | -49.3% | 0.45 | 180% |
| YCBD cbdMD |
Pharmaceuticals
CBD Capsules, Edibles, Topicals |
5.97M | 21.4% | - | -95.5% | 1.31 | -84.2% |
| SXTP 60 Degrees |
Pharmaceuticals
Arakoda, Tafenoquine, Celgosivir |
5.09M | 46.8% | - | -94.8% | 17.7 | -85.7% |
| STENO Stenocare AS |
Pharmaceuticals
Medical, Cannabis, Oil, Products |
4.59M | 42.5% | - | -81.9% | - | -59.9% |